stella
beta
Evaluating the Effect Of Rifaximin on the Gut Microbiota and Metabolome in SIBO Using CapScan® — Stella
Recruiting
Back to Small Intestinal Bacterial Overgrowth trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
Silicon Valley Gastroenterology, Mountain View, California
View full record on ClinicalTrials.gov